Type 2 diabetes mellitus and bone

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 2, 2018-02 ,pp. : 140-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus

By Kanazawa I.   Yamaguchi T.   Yano S.   Yamamoto M.   Yamauchi M.   Kurioka S.   Sugimoto T.  

Osteoporosis International, Vol. 21, Iss. 12, 2010-12 ,pp. : 2013-2018

Springer Publishing Company

Access to resources Recommend Favorite

Personalized pharmacotherapy for Type 2 diabetes mellitus

By Sathananthan Airani   Vella Adrian  

Personalized Medicine, Vol. 6, Iss. 4, 2009-07 ,pp. : 417-422

Future Medicine

Access to resources Recommend Favorite

Atrial electromechanical delay in type 2 diabetes mellitus

By Akyel Ahmet   Öksüz Fatih   Karadeniz Muhammed   Yarlıoğlueş Mikail   Ergün Gökhan   Cankurt Tayyar   Yozgat Ahmet   Keskin Arıel Müge   Aral Yalçın   Murat Sani Namık  

Wiener klinische Wochenschrift, Vol. 126, Iss. 3-4, 2014-02 ,pp. : 101-105

Springer Publishing Company

Access to resources Recommend Favorite

Treatment intensification in type 2 diabetes mellitus and obesity

By Zawiejska Agnieszka   McAleese Jane   Yemparala Prasad   Taheri Shahrad  

British Journal of General Practice, Vol. 63, Iss. 609, 2013-04 ,pp. : 182-182

Royal College of General Practitioners

Access to resources Recommend Favorite